Omega Therapeutics
Cambridge
About Omega Therapeutics
Omega Therapeutics, Inc. is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $279.4M
- Funding stage: M&A
- Last round: Post-IPO Equity (Feb 2023)
- Ticker: nasdaq:OMGA
- Website: omegatherapeutics.com
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/omega-therapeutics-39896 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.